Skip to main content
. 2018 Apr 16;2018:5018671. doi: 10.1155/2018/5018671

Figure 1.

Figure 1

CXCR4 and CXCL12 expression in luminal B BC samples. (a) Immunohistochemical analysis showing a higher expression of CXCR4 protein in the primary tumors of relapsing compared to relapse-free luminal B BC patients. (b) Immunohistochemical analysis of CXCL12 protein levels in the primary tumors of relapsing and relapse-free luminal B BC patients. (i) 10x magnification and (ii) 20x magnification.